FILE:PFE/PFE-8K-20070927143633.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers	Financial Statements and Exhibits
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
ITEM: Financial Statements and Exhibits
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
 

NEW YORK, September 27 -- Pfizer Inc announced today the election of Suzanne Nora Johnson and James M. Kilts to the Pfizer Board of Directors effective September 27, 2007.
Ms. Johnson, 50, retired as Vice Chairman of The Goldman Sachs Group Inc. in January 2007. She had been with the firm for 21 years in roles ranging from the head of health care investment banking to the head of global research and the Chairman of the Global Markets Institute. Ms. Johnson was cited as one of the most powerful women on Wall Street and listed in
Forbes Magazine's 100 Most Powerful Women in the World in 2006.
Ms. Johnson serves as a Director of Intuit and VISA as well as a number of nonprofit organizations including the American Red Cross, the Brookings Institution, the Carnegie Institution of Washington and the University of Southern California.
Ms. Johnson earned her J.D. from Harvard Law School and her Bachelor of Arts from the University of Southern California.
Mr. Kilts, 59, has a distinguished career in business, serving as chief executive officer of three global consumer product companies. He is currently a founding partner of Centerview Partners, a private equity and financial advisory firm, and author of . Previously, Mr. Kilts was Vice Chairman of the Board of The Procter & Gamble Company from 2005-2006. He served as Chairman and Chief Executive Officer of The Gillette Company from 2001 to 2005 and President from 2003-2005 prior to its merger with Procter and Gamble.
Doing What Matters: How to Get Results that Make A Difference
Before joining Gillette, Mr. Kilts was President and Chief Executive Officer of Nabisco Group Holdings Corp. from January 1998 until it was acquired in December 2000 by Philip Morris Companies, Inc., now Altria Group Inc.
Mr. Kilts is a member of the Board of Directors of MetLife, Inc., The New York Times Company and MeadWestvaco Corporation. He serves on the Board of Trustees of Knox College and the University of Chicago and is Chairman of the Advisory Council of the University of Chicago Graduate School of Business.
A graduate of Knox College in Illinois, Mr. Kilts received a Master's Degree in Business Administration from the University of Chicago.
# # # # #


